Drug company gives ofatumumab update
Drug company gives ofatumumab update
Biotech firm Genmab has announced an update on development plans for ofatumumab in autoimmune indications focusing on relapsing multiple sclerosis following the transfer of the rights to ofatumumab from GlaxoSmithKline (GSK) to Novartis at the end of 2015...Read more - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1281 Views
-
Last post by frodo
-
- 0 Replies
- 946 Views
-
Last post by frodo
-
- 0 Replies
- 2294 Views
-
Last post by NHE
-
- 0 Replies
- 1255 Views
-
Last post by frodo
-
- 0 Replies
- 1215 Views
-
Last post by frodo
-
- 0 Replies
- 1171 Views
-
Last post by frodo
-
- 0 Replies
- 1424 Views
-
Last post by NHE
-
- 0 Replies
- 463 Views
-
Last post by NHE
-
- 1 Replies
- 2895 Views
-
Last post by Tif